Search results for: 'biologics contract development ad manufacturing organizations'

This edition of the Life Science, Health & Wellness Technology Opportunity Engine (TOE) provides insights across recent developments for intelligent drug discovery solutions, precision oncology and novel biologics. The TOE also comprises innovations across stem cell therapies and radiotherapies.The Life Science, Health & Wellness TOE will feature d...

25 Jul 2016  |  Europe  |  Market Research

Analysis of the Global Biologics API Market

Redefining the Future of Biologics through Target-specific Drugs and Novel Technologies

Infographics

×

This study provides an insight into the global biologics active pharmaceutical ingredients (API) market. According to the US FDA, “Biological products, or biologics, are medical products made from a variety of natural sources (human, animal, or microorganism). Biologics are intended to treat diseases & medical conditions and prevent or diagnose dis...

10 Sep 2024  |  Global  |  Technology Research

Technology Advances in Modular and Automated Platforms for Pharmaceutical Manufacturing

Increasing demand for small molecule drugs is driving the growth of modular and automated technologies in pharmaceutical manufacturing

Infographics

×

This study examines technology advances in modular and automated platforms for non-biologics manufacturing in the pharmaceutical sector. There is a growing demand for automated and modular technologies that ensure regulatory compliance, increase productivity, reduce waste, and meet emerging therapeutic requirements such as those of the personalized...

Immuno-oncology (I-O) therapies target tumors by harnessing the host s immune system. With the growing incidence and prevalence of various types of aggressive and refractory cancers, the next-generation I-O therapy pipeline has witnessed significant growth. Chimeric antigen receptor (CAR)-T cell therapy and tumor-targeted antibody therapies, includ...

The global pharmaceutical research and development (R&D) pipeline accounts for more than 21,000 molecules, as of April 2023, indicating a 5.8% hike over 2022, with more than 6,100 molecules in active development. In general, however, the pharma/biopharma industry has stagnated with respect to R&D activity. Overall R&D expenditure totals about $276....

This edition of the Life Science, Health & Wellness Technology Opportunity Engine (TOE) provides actionable insights across new developments in oncology, immunology, autoimmune disorders, and precision medicine, highlighting next-generation biologics, bispecific antibodies, kinase inhibitors, molecular glues, and antibody engineering platforms. The...

10 Aug 2022  |  Global  |  Market Research

Global Satellite Component Manufacturing Growth Opportunities

Distributed Governance, Digital Technologies, Cyber Resilience, & Standardized Commercial-off-the-Shelf Components to Stimulate the Growing NewSpace Economy

Infographics

×

An emerging commercial space industry, driven primarily by satellite miniaturization for low Earth orbit (LEO) operation, has disrupted space regimes. With 4,852 satellites in orbit and an expected capacity of 19,282 by 2030, the development of the downstream sector has been influenced by solid space technology advancements and broader global techn...

The development of augmented reality (AR), virtual reality (VR), and extended reality (XR) technologies expect to accelerate in upcoming years. Technology developers and adopters across various industries experiment with these innovations for mass deployment, driving the shift from product testing for specific application requirements to scaling th...

Environmental concerns are compelling governments and companies to switch to a green manufacturing model. Manufacturers across various sectors may have different motivations to adopt sustainable practices; for some, it could be complying with government regulations, while for others, it could be to build a green label and gain customer loyalty or i...